SPG7-Mediated Regulation of mPTP and Mitochondrial Flickering in COPD: A Bioinformatics-Based Prediction of

Anran Xu1, Yaping Lv2, Shaobin Li1

  • 1Department of Traditional Chinese Medicine Preventive Health Care, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, People's Republic of China.

Abstract

Insights

Chronic obstructive pulmonary disease (COPD) progression disrupts mitophagy. This study identifies SPG7 as a potential biomarker for acute exacerbations of COPD (AECOPD), suggesting a protective role for mitochondrial permeability transition pore opening.

Area of Science:

  • Mitochondrial biology
  • Pulmonary medicine
  • Bioinformatics

Background:

  • Mitophagy homeostasis is disrupted during chronic obstructive pulmonary disease (COPD) progression, playing a dual role.
  • The regulation of mitophagy by mitochondrial membrane potential (ΔΨm) and mitochondrial permeability transition pore (mPTP) dynamics in COPD is not well understood.
  • Stage-specific roles of mitophagy in COPD progression require further investigation.

Purpose of the Study:

  • To investigate the role of mPTP-related genes in COPD progression.
  • To identify potential biomarkers for COPD state transitions.
  • To explore the underlying mechanisms of mitophagy regulation in COPD.

Main Methods:

  • Utilized differential analysis and Mendelian randomization (MR) to link mPTP-related genes with COPD.
  • Validated key biomarkers through gene enrichment, functional annotation, immune infiltration, and single-cell RNA sequencing (scRNA-seq).
  • Employed molecular docking to confirm the potential roles of identified biomarkers.

Main Results:

  • Acute exacerbation of COPD (AECOPD) is characterized by increased AT2 cell death, hyperinflammation, and energy demand.
  • Six biomarkers, including SPG7, were associated with AECOPD; SPG7 showed a positive correlation.
  • SPG7 expression correlated with energy demand and interacted with AFG3L2 and PPIF, suggesting a role in mPTP regulation.

Conclusions:

  • The study supports the mitochondria-cell survival hypothesis in COPD.
  • Bioinformatic analysis indicates mPTP-triggered mitochondrial flickering maintains quality control.
  • Transient mPTP opening via SPG7-mediated CypD activation may offer a protective pathway in COPD, requiring experimental validation.